Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Pfizer
M.D. Anderson Cancer Center
Centre Oscar Lambret
Pfizer
MacroGenics
Yale University
Bolt Biotherapeutics, Inc.
Tempus AI
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Pfizer
Pfizer
Numab Therapeutics AG
NuCana plc
University of Virginia
NRG Oncology
M.D. Anderson Cancer Center
Mayo Clinic
Turnstone Biologics, Corp.
Kymab Limited
Incyte Corporation
Seagen Inc.
Incyte Corporation
Seagen Inc.
University of California, San Diego
ImaginAb, Inc.
Pfizer
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Rain Oncology Inc
Novartis
Pfizer
Pfizer
ADC Therapeutics S.A.
Pfizer
Vanderbilt University Medical Center
Atreca, Inc.
University of Florida
Novartis
Fate Therapeutics
Fate Therapeutics
Hoffmann-La Roche
4D pharma plc
Calithera Biosciences, Inc
Nektar Therapeutics
Advaxis, Inc.
Rubius Therapeutics
Duke University